HLA-G activators encompass a range of chemicals that indirectly influence the expression or function of Human Leukocyte Antigen G (HLA-G), a non-classical MHC class I molecule. This group primarily includes immunomodulatory agents, epigenetic modifiers, and hormones, each affecting HLA-G through distinct mechanisms. Immunomodulatory agents such as IFN-γ, IL-10, and corticosteroids play a significant role in the regulation of immune responses, which can lead to changes in HLA-G expression. IFN-γ and IL-10, for instance, are cytokines with critical roles in immune system signaling. They can modulate the expression of HLA-G, thereby influencing immune tolerance mechanisms. Corticosteroids, widely known for their immune-suppressing properties, might also affect HLA-G levels as part of their broad regulatory effects on immune cells and cytokine production.
On the other hand, epigenetic modifiers like 5-Azacytidine and Trichostatin A impact HLA-G expression by altering gene expression patterns without changing the DNA sequence. 5-Azacytidine inhibits DNA methyltransferases, leading to the demethylation and activation of certain genes, including those related to immune functions like HLA-G. Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure, thereby modulating gene expression profiles, including HLA-G. Additionally, hormones such as progesterone and estrogen, particularly relevant during pregnancy, have been suggested to modulate HLA-G expression. Their role in maintaining pregnancy aligns with the function of HLA-G in fostering maternal-fetal tolerance. Vitamin D, also involved in immune regulation, can influence HLA-G expression, linking bone metabolism and immune responses. HLA-G activators are a diverse group of chemicals that indirectly modulate the expression and function of HLA-G. Their mechanisms of action include immunomodulation, epigenetic modification, and hormonal regulation, reflecting the multifaceted nature of HLA-G in immune tolerance and response. This understanding is crucial in contexts where modulation of immune tolerance is desired, such as in transplantation, autoimmunity, and pregnancy-related immunology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can influence HLA-G expression through epigenetic modifications. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
A compound that may have indirect effects on HLA-G expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An immunosuppressant that might influence HLA-G levels indirectly through mTOR pathway modulation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
May modulate HLA-G expression as part of its role in immune regulation. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Has been suggested to modulate HLA-G expression, especially in pregnancy-related contexts. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Similar to progesterone, it may influence HLA-G expression in certain physiological conditions. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
A component of licorice that might have indirect effects on HLA-G expression through immune pathways. | ||||||